🇺🇸 FDA
Patent

US 7754227

Method of immunizing humans against Salmonella typhi using a Vi-rEPA conjugate vaccine

granted A61KA61K2039/6037A61K2039/6068

Quick answer

US patent 7754227 (Method of immunizing humans against Salmonella typhi using a Vi-rEPA conjugate vaccine) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jul 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jul 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K2039/6037, A61K2039/6068, A61K2039/627, A61K39/0275